BlackRock Health Sciences Term Trust (NYSE:BMEZ – Get Free Report) saw a significant drop in short interest in December. As of December 31st, there was short interest totalling 48,200 shares, a drop of 61.2% from the December 15th total of 124,200 shares. Based on an average daily volume of 365,000 shares, the short-interest ratio is currently 0.1 days.
Institutional Inflows and Outflows
Large investors have recently made changes to their positions in the company. Brown Brothers Harriman & Co. bought a new stake in BlackRock Health Sciences Term Trust in the third quarter worth about $32,000. K2 Principal Fund L.P. bought a new stake in BlackRock Health Sciences Term Trust in the third quarter worth about $158,000. Dakota Wealth Management raised its position in BlackRock Health Sciences Term Trust by 23.4% in the third quarter. Dakota Wealth Management now owns 22,509 shares of the company’s stock worth $357,000 after acquiring an additional 4,267 shares during the period. Jane Street Group LLC bought a new stake in BlackRock Health Sciences Term Trust in the third quarter worth about $357,000. Finally, Brown Lisle Cummings Inc. raised its position in BlackRock Health Sciences Term Trust by 6.2% in the third quarter. Brown Lisle Cummings Inc. now owns 36,513 shares of the company’s stock worth $578,000 after acquiring an additional 2,128 shares during the period.
BlackRock Health Sciences Term Trust Price Performance
BMEZ opened at $15.25 on Thursday. The company’s 50-day moving average is $15.29 and its 200 day moving average is $15.58. BlackRock Health Sciences Term Trust has a fifty-two week low of $14.27 and a fifty-two week high of $16.59.
BlackRock Health Sciences Term Trust Dividend Announcement
About BlackRock Health Sciences Term Trust
BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.
Read More
- Five stocks we like better than BlackRock Health Sciences Term Trust
- The 3 Best Fintech Stocks to Buy Now
- 4 Social Media Stocks Set to Gain as TikTok Ban Looms
- The Most Important Warren Buffett Stock for Investors: His Own
- How Do Stock Buybacks Affect Shareholders?
- How to Invest in the Best Canadian StocksĀ
- JPMorgan Chase & Co. Stock Can Hit $300 This Year
Receive News & Ratings for BlackRock Health Sciences Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.